Shareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights - ANRO

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit on behalf of shareholders of Alto Neuroscience, Inc. (NYSE: ANRO) due to allegations of misleading statements regarding the effectiveness of its product pipeline, ALTO-100 [1][2]. Group 1: Allegations and Class Period - The lawsuit claims that during the class period, the defendants made materially false and misleading statements about ALTO-100's effectiveness in treating major depressive disorder, overstating its clinical, regulatory, and commercial prospects [2]. - The class period for the lawsuit includes all persons and entities that purchased Alto common stock from February 2, 2024, to October 22, 2024 [1][2]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by September 19, 2025, to potentially be appointed as lead plaintiffs and to receive updates on the case [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered losses due to deceit and fraud, emphasizing the importance of responsible business practices [4].